Related content

Expression of brainspecific angiogenesis inhibitor1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell carcinoma

By Tian Dawei   Hu Hailong   Sun Yan   Tang Yang   Lei Mingde   Liu Liwei   Han Ruifa   Wu Changli  

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-09 ,pp. : 4522-4529

Spandidos Publications

Access to resources Recommend Favorite

Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells

By Yasumatsu Ryuji   Nakashima Torahiko   Masuda Muneyuki   Ito Aya   Kuratomi Yuichiro   Nakagawa Takashi   Komune Shizuo  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 10, 2004-10 ,pp. : 567-573

Springer Publishing Company

Access to resources Recommend Favorite

Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling

By  

Molecular Medicine Reports, Vol. 11, Iss. 3, 2015-01 ,pp. : 2167-2172

Spandidos Publications

Access to resources Recommend Favorite

Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review

By                                                          

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 5-16

Spandidos Publications

Access to resources Recommend Favorite

Transitional Cell Carcinoma of the Endometrium

By Spiegel G.W.   Austin MD R.M.   Gelven P.L.  

Gynecologic Oncology, Vol. 60, Iss. 2, 1996-02 ,pp. : 325-330

Academic Press

Access to resources Recommend Favorite